AIM WINNERS & LOSERS: Tavistock Rises As Tips Annual Earnings Climb Read More
No Conditional US Approval So Far For ImmuPharma Lupus Drug Lupuzor Read More
UK TRADING UPDATE SUMMARY: Gore Street Energy Energises Drumkee Read More
IN BRIEF: Immupharma Says L1 Capital Converts USD200,000 Of Security Read More
ImmuPharma Partner To Discuss Progression Of Lupuzor Drug With US FDA Read More
UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter Read More
UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise Read More
IN BRIEF: Immupharma Raises Stake In Incanthera To 15.4% Read More
IN BRIEF: Immupharma Repays Lind Global Convertible Security Read More
IN BRIEF: Immupharma Still Awaiting FDA Reply For Lupuzor Submission Read More
Immupharma Raises GBP6.5 Million In Oversubscribed Placing Read More
IN BRIEF: ImmuPharma Partner Avion Submits Request To FDA For Lupuzor Read More
UK Shareholder Meetings Calendar - Next 7 Days Read More
Immupharma Gets Over USD6 Million Investment From US Healthcare Funds Read More
UK TRADING UPDATE SUMMARY: Byotrol Sees Continuation Of Strong Demand Read More
ImmuPharma Annual Loss Narrows; Plans "Optimised" Lupuzor Trial Read More
ImmuPharma Raises GBP1.5 Million Through Share Issue To Fund Expansion Read More
Immupharma Inks Subscription Agreement Amid Incanthera's NEX Float Read More
ImmuPharma To List On Life Sciences Heavy Brussels Index Read More
ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise Read More
